uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Varying intervals of subcutaneous epoetin alfa in hemodialysis patients
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
2004 (English)In: JN. Journal of Nephrology (Milano. 1992), ISSN 1121-8428, Vol. 17, no 4, 525-530 p.Article in journal (Other academic) Published
Abstract [en]

BACKGROUND: The optimal subcutaneous (SC) epoetin alfa strategy is unestablished. The individual variability in dose requirements needs consideration. In this study, prolonged intervals were assessed in relation to varying dose requirements. METHODS: The study included 153 hemodialysis (HD) patients on stable SC epoetin alfa. Based on dose requirements, the patients received either 4,000 U (group I, n=51) or 10,000 U (group II, n=102) as whole 1 mL vials at prolonged intervals. The study comprised three 8-week periods: an initial period maintaining the basal regimens, an adjustment period where the intervals were prolonged, and a maintenance period. Alterations in hemoglobin (Hb), weekly doses and intervals in each group were compared. RESULTS: One hundred and thirty-seven patients completed the study (48 in group I and 89 in group II). In group I, the mean interval was prolonged from 5.4 +/- 1.9 to 7.8 +/- 3.1 days (p=0,01) with stable Hb and EPO doses. In group II, prolonged intervals were associated with a reduction in mean Hb below target level and a significant increase in EPO doses (p=0,002). Iron deficiency and inflammation could explain the poor response in approximately one-third of the patients. CONCLUSIONS: In HD patients, the optimal injection frequency should be individually adjusted. Prolonged intervals can be applied to patients with low-dose requirements. Observing iron status and inflammation is necessary for optimal response.

Place, publisher, year, edition, pages
2004. Vol. 17, no 4, 525-530 p.
Keyword [en]
Aged, Anemia; Hypochromic/*drug therapy/etiology, Comparative Study, Dose-Response Relationship; Drug, Drug Administration Schedule, Epoetin Alfa/*administration & dosage, Female, Follow-Up Studies, Hemoglobins/drug effects, Humans, Injections; Subcutaneous, Kidney Failure; Chronic/diagnosis/*therapy, Male, Middle Aged, Prospective Studies, Renal Dialysis/*adverse effects/methods, Risk Assessment, Sweden, Treatment Outcome
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-74269PubMedID: 15372414OAI: oai:DiVA.org:uu-74269DiVA: diva2:102179
Available from: 2005-09-19 Created: 2005-09-19 Last updated: 2010-09-30Bibliographically approved

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Wikström, Björn
By organisation
Department of Medical Sciences
In the same journal
JN. Journal of Nephrology (Milano. 1992)
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 186 hits
ReferencesLink to record
Permanent link

Direct link